PRESS RELEASE
News
-
-
-
-
REGULATED PRESS RELEASE
NFL Biosciences strengthens its scientific committee with world-class experts to support the Phase 3 development of NFL-101, its first-in-class therapy for tobacco addiction
NFL Biosciences strengthens scientific committee with world-class experts for Phase 3 development of NFL-101, a breakthrough therapy for tobacco addiction -
-
PRESS RELEASE
Strongest first quarter in the company's history: JDC achieved consolidated revenue of over EUR 60 million for the first time at the start of the year
JDC Group AG achieves record first-quarter revenue exceeding EUR 60 million. Revenue up by 16.7%. EBITDA increased by 23.9%. Positive outlook for 2025 growth -
PRESS RELEASE
DMS GROUP: FDA CLEARANCE FOR THE !M1 SYSTEM AND THE IMMEDIATE COMMERCIALIZATION IN THE UNITED STATES WITH MEDLINK IMAGING
Diagnostic Medical Systems obtains FDA clearance for commercialization of !M1 mobile radiology solution in the U.S. market, partnering with Medlink Imaging for distribution -
PRESS RELEASE
PPF announces all-cash offer of EUR 7.00 per share to increase its ProSiebenSat.1 stake up to 29.99%
PPF announces all-cash offer of EUR 7.00 per share to increase ProSiebenSat.1 stake up to 29.99%, providing shareholders with a compelling alternative. Offer enhances strategic shareholding and supports ProSiebenSat.1's transformation -
PRESS RELEASE
EQS-Adhoc: ProSiebenSat.1 Media SE: PPF announces public acquisition offer to increase its stake in ProSiebenSat.1 to up to 29.99%
PPF announces public acquisition offer to increase stake in ProSiebenSat.1 Media SE to up to 29.99% at 7.00 euros per share. ProSiebenSat.1 welcomes the offer with support for its strategy -
PRESS RELEASE
Verve Group SE Starts Trading on the Regulated Market of the Frankfurt Stock Exchange under the Ticker Symbol 'VRV'
Verve Group SE successfully completes uplisting to the Regulated Market of the Frankfurt Stock Exchange, trading under the ticker symbol 'VRV'. Expands investor base and eyes SDAX inclusion
